Insider Buying: Auna (NYSE:AUNA) President Acquires $97,746.60 in Stock

Auna S.A. (NYSE:AUNA) President Leon Jesus Zamora acquired 23,273 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were bought at an average cost of $4.20 per share, for a total transaction of $97,746.60. Following the completion of the acquisition, the president owned 62,710 shares of the company’s stock, valued at approximately $263,382. This represents a 59.01% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Leon Jesus Zamora also recently made the following trade(s):

• On Tuesday, May 26th, Leon Jesus Zamora acquired 8,727 shares of Auna stock. The shares were bought at an average cost of $4.24 per share, for a total transaction of $37,002.48.

Auna Stock Performance

AUNA opened at $4.16 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.09 and a debt-to-equity ratio of 1.76. The company has a market cap of $307.88 million, a price-to-earnings ratio of 16.00 and a beta of 1.03. Auna S.A. has a 52-week low of $4.09 and a 52-week high of $6.85. The firm’s fifty day simple moving average is $5.22 and its two-hundred day simple moving average is $5.02.

Auna (NYSE:AUNA) last posted its quarterly earnings data on Friday, May 15th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.14). The company had revenue of $336.84 million for the quarter, compared to analysts’ expectations of $320.54 million. Auna had a net margin of 1.53% and a return on equity of 16.25%. Equities analysts anticipate that Auna S.A. will post 0.81 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Auna

A number of institutional investors have recently bought and sold shares of AUNA. Renaissance Technologies LLC raised its stake in Auna by 487.7% during the first quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock worth $3,683,000 after purchasing an additional 554,707 shares during the period. Marshall Wace LLP increased its position in shares of Auna by 391.0% during the fourth quarter. Marshall Wace LLP now owns 162,992 shares of the company’s stock valued at $802,000 after acquiring an additional 129,799 shares during the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Auna during the first quarter valued at about $557,000. Hsbc Holdings PLC acquired a new stake in shares of Auna during the first quarter valued at about $324,000. Finally, Arrowstreet Capital Limited Partnership acquired a new stake in shares of Auna during the first quarter valued at about $316,000.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on AUNA shares. JPMorgan Chase & Co. decreased their price target on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. Zacks Research downgraded shares of Auna from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. Weiss Ratings reissued a “sell (d)” rating on shares of Auna in a research note on Friday, March 27th. Finally, Wall Street Zen downgraded shares of Auna from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 16th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Auna currently has an average rating of “Hold” and an average price target of $6.97.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.